Channel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRO and other ETFs, options, and stocks.

About CHRO

Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of therapeutics. It focuses on non-opioid therapy of chronic eye pain. 

CEO
Francis P. Knuettel
CEOFrancis P. Knuettel
Employees
8
Employees8
Headquarters
Freehold, New Jersey
HeadquartersFreehold, New Jersey
Founded
2002
Founded2002
Employees
8
Employees8

CHRO Key Statistics

Market cap
6.76M
Market cap6.76M
Price-Earnings ratio
-0.60
Price-Earnings ratio-0.60
Dividend yield
—
Dividend yield—
Average volume
142.61K
Average volume142.61K
High today
—
High today—
Low today
—
Low today—
Open price
$1.05
Open price$1.05
Volume
0.00
Volume0.00
52 Week high
$3.80
52 Week high$3.80
52 Week low
$0.45
52 Week low$0.45

People also own

Based on the portfolios of people who own CHRO. This list is generated using Robinhood data, and it’s not a recommendation.
SoundHound AI
Quantum Computing
D-Wave Quantum
BigBear.ai
XTI Aerospace, Inc.
KULR Technology Group
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.